2021
DOI: 10.3390/healthcare9020211
|View full text |Cite
|
Sign up to set email alerts
|

Cost-Effectiveness Analysis of Type 2 Diabetes Mellitus (T2DM) Treatment in Patients with Complications of Kidney and Peripheral Vascular Diseases in Indonesia

Abstract: Type 2 diabetes mellitus (T2DM) is a chronic disease with high-cost treatment. This study aimed to analyze the cost-effectiveness of T2DM treatment in hospitalized patients with complications of kidney and peripheral vascular disease (PVD) in Indonesia by focusing on patients of Health Social Security Agency (BPJS Kesehatan). An observational study was applied by collecting data retrospectively from patients’ medical record at the biggest public hospital in West Java Province, Indonesia. Two perspectives of pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 36 publications
(39 reference statements)
0
11
0
1
Order By: Relevance
“…ZINB produced the lowest AIC in the simulation scenarios with proportion of structural zeros greater than 50% and dispersion equal to 1. Similarly, at level of dispersion equal to 1 the model that produced the lowest BIC was the NB model Tables 19,20,21,22. In scenarios with a small sample size of 50 and dispersion levels of 0.01 and 1, the ZIP model provided the smallest MAEs in nearly all simulation scenarios of proportion of structural zero, except for the scenarios with structural zero proportion of 70% and dispersion level of 0.01. Another exception were the scenarios with structural zero proportion of 10% and dispersion level of 1, where ZINB and Poisson regression models had the smallest MAEs, respectively.…”
Section: Data Generated With Zinb Regression Modelmentioning
confidence: 95%
See 1 more Smart Citation
“…ZINB produced the lowest AIC in the simulation scenarios with proportion of structural zeros greater than 50% and dispersion equal to 1. Similarly, at level of dispersion equal to 1 the model that produced the lowest BIC was the NB model Tables 19,20,21,22. In scenarios with a small sample size of 50 and dispersion levels of 0.01 and 1, the ZIP model provided the smallest MAEs in nearly all simulation scenarios of proportion of structural zero, except for the scenarios with structural zero proportion of 70% and dispersion level of 0.01. Another exception were the scenarios with structural zero proportion of 10% and dispersion level of 1, where ZINB and Poisson regression models had the smallest MAEs, respectively.…”
Section: Data Generated With Zinb Regression Modelmentioning
confidence: 95%
“…Hospital LOS is often used as a measure of a post-medical procedure outcome, as a guide to the benefit of a treatment of interest, and/or as an important risk factor for adverse events, hospital readmission, and mortality [11][12][13]. Therefore, understanding hospital LOS variability across various patients' clinical and socio-demographic characteristics and hospitals' characteristics, such as geographic region and hospital sizes, is always an important public health focus [9,[14][15][16][17][18][19][20][21][22].…”
Section: Introductionmentioning
confidence: 99%
“… f WHO guide to cost-effectiveness analysis and WHO guide for standardization of economic evaluations of immunization programmes. 23 , 24
Fig. 2 Frequency of studies by disease type.
…”
Section: Resultsmentioning
confidence: 99%
“…This has been reported well in all of the studies post-2018, except for one study comparing ‘treatments’ for diabetes patients with different complications without defining the treatments. 24 Without a proper explanation of the intervention, the study may be potentially misleading.…”
Section: Resultsmentioning
confidence: 99%
“…Preventative measures are needed to improve patients' glycemic control, thereby preventing diabetes complications, which could potentially reduce the health and economic burden on the public health care system. [1][2][3] Based on International Diabetes Federation (IDF) data for 2021, Indonesia is globally ranked fifth with 19.5 million adults aged 20-79 years living with diabetes. Referring to the IDF data, the number of people with Diabetes Mellitus in Indonesia is projected to increase to 28.6 million in 2045.…”
Section: Introductionmentioning
confidence: 99%